Clinical Trial Update: Radiofrequency Ablation in Resectable Colorectal Lung Metastasis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating radiofrequency ablation for resectable colorectal cancer that has metastasized to the lung.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Lung Metastasis

Snippet

Sponsor: Mie University | Conditions: Lung Metastasis, Colorectal Cancer | Phase 2 | Status: COMPLETED